Benitec Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BNTC and other ETFs, options, and stocks.About BNTC
Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firm's proprietary platforms include DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration.
CEOJerel A. Banks
CEOJerel A. Banks
Employees19
Employees19
HeadquartersHayward, California
HeadquartersHayward, California
Founded1995
Founded1995
Employees19
Employees19
BNTC Key Statistics
Market cap433.44M
Market cap433.44M
Price-Earnings ratio-13.11
Price-Earnings ratio-13.11
Dividend yield—
Dividend yield—
Average volume241.68K
Average volume241.68K
High today$13.30
High today$13.30
Low today$12.78
Low today$12.78
Open price$13.26
Open price$13.26
Volume68.53K
Volume68.53K
52 Week high$17.15
52 Week high$17.15
52 Week low$9.49
52 Week low$9.49
Stock Snapshot
As of today, Benitec Biopharma(BNTC) shares are valued at $12.80. The company's market cap stands at 433.44M, with a P/E ratio of -13.11.
On 2025-12-05, Benitec Biopharma(BNTC) stock moved within a range of $12.78 to $13.30. With shares now at $12.80, the stock is trading +0.2% above its intraday low and -3.8% below the session's peak.
Trading activity shows a volume of 68.53K, compared to an average daily volume of 241.68K.
The stock's 52-week range extends from a low of $9.49 to a high of $17.15.
The stock's 52-week range extends from a low of $9.49 to a high of $17.15.
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own BNTC. This list is generated using Robinhood data, and it’s not a recommendation.